Cardinal Enterprise Value Multiple from 2010 to 2024

CAH Stock  USD 122.63  0.19  0.16%   
Cardinal Health's Enterprise Value Multiple is increasing with stable movements from year to year. Enterprise Value Multiple is predicted to flatten to 7.95. For the period between 2010 and 2024, Cardinal Health, Enterprise Value Multiple quarterly trend regression had median of  10.25 and r-value of  0.24. View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
12.08806876
Current Value
7.95468278
Quarterly Volatility
29.15515112
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardinal Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardinal Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 360.6 M, Interest Expense of 48.5 M or Selling General Administrative of 5.2 B, as well as many indicators such as Price To Sales Ratio of 0.21, Dividend Yield of 0.004 or PTB Ratio of 1.58. Cardinal financial statements analysis is a perfect complement when working with Cardinal Health Valuation or Volatility modules.
  
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.

Latest Cardinal Health's Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Cardinal Health over the last few years. It is Cardinal Health's Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardinal Health's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Pretty Stable
   Enterprise Value Multiple   
       Timeline  

Cardinal Enterprise Value Multiple Regression Statistics

Arithmetic Mean17.55
Coefficient Of Variation166.14
Mean Deviation14.07
Median10.25
Standard Deviation29.16
Sample Variance850.02
Range128
R-Value0.24
Mean Square Error861.66
R-Squared0.06
Significance0.38
Slope1.58
Total Sum of Squares11,900

Cardinal Enterprise Value Multiple History

2024 7.95
2023 12.09
2022 17.59
2021 120.49
2020 14.88
2019 -7.37
2018 6.52

About Cardinal Health Financial Statements

Investors use fundamental indicators, such as Cardinal Health's Enterprise Value Multiple, to determine how well the company is positioned to perform in the future. Although Cardinal Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Enterprise Value Multiple 12.09  7.95 

Currently Active Assets on Macroaxis

When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:
Check out the analysis of Cardinal Health Correlation against competitors.
For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
48.135
Dividend Share
2.012
Earnings Share
5.21
Revenue Per Share
921.782
Quarterly Revenue Growth
(0.04)
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.